1932

Abstract

This review surveys the developing market for direct-to-consumer (DTC) genetic tests and examines the range of companies and tests available, the regulatory landscape, the concerns raised about DTC testing, and the calls for enhanced oversight. We provide a comparative overview of the situation, particularly in the United States and Europe, by exploring the regulatory frameworks for medical devices and clinical laboratories. We also discuss a variety of other mechanisms such as general controls on advertising and consumer law mechanisms.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.genom.9.081307.164319
2008-09-22
2024-04-15
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.genom.9.081307.164319
Loading
/content/journals/10.1146/annurev.genom.9.081307.164319
Loading

Data & Media loading...

Supplemental Material

Supplementary Data

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error